05-Jul-2006 - A dry powder nasal flu vacccine is being hailed by its developers at DelSite Biotechnologies as a unique storage solution, providing delivery advantages over traditional flu vaccines in the event of a bird flu pandemic.
04-Jul-2006 - New guidelines for the import and manufacture of medical devices in India have now come into effect, aimed at increasing world confidence in medical devices made in the region.
03-Jul-2006 - Intec Pharma has enlisted two North American dosage form manufacturers to make "supergenerics" using its new method of oral drug delivery that can transform existing drugs into more powerful therapies.
28-Jun-2006 - Innovata is moving forward with its dry powder pulmonary insulin inhaler, which it claims has a formulation superior to Exubera, gearing up for Phase II clinical trials and anticipating a new partnership deal by the end of the year.
27-Jun-2006 - As the shortage of cartridges of its injectable diabetes drug Byetta reaches critical levels, Amylin Pharmaceuticals is seeking to expand manufacturing capacity and is exploring a nasal spray formulation of the medicine with drug delivery firm Nastech.
27-Jun-2006 - Researchers have developed a new nanocarrier system for the delivery of drugs which contains iron and so can be directed by a magnetic field to specific areas of the body, a technology which could prove invaluable in the treatment of diseases such as cancer.
26-Jun-2006 - SkyePharma used its latest business review meeting to announce the imminent arrival of a new rheumatoid arthritis (RA) drug formulated using its novel controlled release drug delivery technology.
22-Jun-2006 - Looking for an edge in both proprietary and off-patent products, Plethora Solutions has licensed two drug delivery platforms from Maelor Pharmaceuticals and Metris Therapeutics in the UK.
22-Jun-2006 - Vaccine developer Iomai has solidified its position in transcutaneous immunisation (TCI) by receiving a new US patent which outlines methods for inducing an immune response to Iomai's novel skin-patch-based vaccines.
21-Jun-2006 - The US Food and Drug Administration (FDA) has urged the pharma industry to develop preservative-free nasal sprays, however, there is currently a vacuum of manufacturers that can fulfil such a requirement.
21-Jun-2006 - Biotech company Genzyme Pharmaceuticals and drug delivery firm Brookwood Pharmaceuticals are now working together to create new ways of delivering peptide-based drugs.
19-Jun-2006 - Many said it couldn't be done, but Australian pharma firm Phosphagenics has developed what it claims is the world's first transdermal insulin formulation and has received the first signs that the product may have blockbuster potential.
12-Jun-2006 - Drug delivery firm Egalet has asked SP Medical, a manufacturer of moulded plastics and coatings, to make sufficient clinical grade quantities of its therapeutics using injection moulding, which allows for greater uniformity and reproducibility in the production of tablets.
12-Jun-2006 - German aerosol delivery firm PARI and UK medical gas provider BOC have agreed to jointly develop new gas-enabled drug delivery systems to help patients with compromised lung function.
12-Jun-2006 - Nastech has secured a contract with Procter & Gamble (P&G) to ramp up manufacturing capacity for a new needle-free drug to beat osteoporosis, in anticipation of meeting expected global demand once the product is approved.
08-Jun-2006 - SurModics has licensed its advanced hydrophilic coating technology to Xtent for use in the delivery system of its novel drug-eluting stent (DES) system, designed to reduce the time, complexity and cost of coronary stent procedures.
08-Jun-2006 - Fine chemicals company Hovione has passed an inspection by the US Food and Drug Administration (FDA) at its active pharmaceutical ingredient (API) manufacturing site in Loures, Portugal, as it tries to conform with ever-stricter standards.
07-Jun-2006 - UK novel drug delivery developer Vectura and UK venture capital firm Unilever Ventures have jointly established a new speciality pharmaceutical company focusing on oral and transdermal drug delivery systems.
07-Jun-2006 - Drug delivery firm MonoSol Rx has inaugurated new analytical laboratories in its manufacturing facility in Indiana which will allow it to integrate all aspects of product development and manufacturing of drug delivery films.
01-Jun-2006 - MAP Pharmaceuticals has awarded the manufacturing of the metered-dose components of its new inhaler devices to Xemplar, who is one of the few contract manufacturers in the world that can take on such a challenge and is now upping manufacturing capacity to meet future demand in this evolving market.
25-May-2006 - Bioprogress has signed a development agreement with emerging speciality pharmaceutical company Uluru to combine their film technologies in order to create an edible film which allows sustained release of active ingredients.
25-May-2006 - Phosphagenics is constructing a new tocopheryl phosphates manufacturing plant in Melbourne, Australia - a project that paves the way for future licensing agreements and could encourage the use of its technology in more of the company's pharmaceutical products.
25-May-2006 - Biophan has filed the first patent to come out of its newly-formed relationship with NaturalNano to develop new and improved ways of controlled-release drug delivery.
25-May-2006 - India's Ranbaxy Laboratories has stepped up its efforts to dominate the domestic novel drug delivery system (NDDS) market, in-licensing two new drugs from Europe in as many weeks.
24-May-2006 - A new polymer drug delivery technology developed by Dutch firm OctoPlus has cleared Phase I trials for the first time, showing promise in a new controlled release treatment of chronic hepatitis C.